William Blair launched coverage of Cardinal Health (NYSE:CAH | CAH Price Prediction) with an Outperform rating today, framing ...

McKesson (MCK) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

The latest trading day saw McKesson (MCK) settling at $842.25, representing a -1.95% change from its previous close.

McKesson’s net income grew at an average rate of 14.4% over the last three years, yet its earnings per share (EPS) increased ...

McKesson said Apollo affiliates agreed to buy a minority ownership interest in its medical-surgical solutions business ahead ...

Somehow, members of Congress have turned relatively modest salaries into impressive investment portfolios while the rest of ...

McKesson is a dependable compounding machine; however, its future direction hinges on management's capacity to implement the ...

By Sahil Pandey and Christy Santhosh April 20 (Reuters) - McKesson will sell a minority stake in its medical-surgical ...

McKesson let go of a minority share of its medical/surgical solutions division for $1.25 billion to Apollo Funds as part of ...

CALGARY, ALBERTA, CANADA, April 28, 2026 /EINPresswire.com/ -- naturemary, a Canadian plant-based wellness company ...

View McKesson Corporation MCK stock quote prices, financial information, real-time forecasts, and company news from CNN.

Goodreid Investment Counsel president and CEO Gordon Reid told BNN Bloomberg’s Market Call on April 23 that McKesson (McKesson Stock Quote, Chart, News, Analysts, Financials NYSE:MCK) remains an ...